NCT03710772 2026-02-11Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting51 enrolled